vs
奎斯特诊断（DGX）与Universal Health Services（UHS）财务数据对比。点击上方公司名可切换其他公司
Universal Health Services的季度营收约是奎斯特诊断的1.6倍（$4.5B vs $2.9B），奎斯特诊断净利率更高（9.7% vs 8.0%，领先1.7%），奎斯特诊断同比增速更快（9.2% vs 8.2%），过去两年奎斯特诊断的营收复合增速更高（9.9% vs 7.3%）
奎斯特诊断是美国头部临床检验服务商，位列《财富》500强，业务覆盖美国、波多黎各、墨西哥及巴西，同时与全球范围内多家医院、诊所保持长期协作关系，为不同地区的客户提供专业临床检验相关服务。
Universal Health Services（简称UHS）是美国财富500强企业，总部位于宾夕法尼亚州普鲁士王市，主营医院运营及各类医疗健康服务，2024年公布的总营收达158亿美元，在全球医疗服务领域具备较强的市场影响力。
DGX vs UHS — 直观对比
营收规模更大
UHS
是对方的1.6倍
$2.9B
营收增速更快
DGX
高出1.0%
8.2%
净利率更高
DGX
高出1.7%
8.0%
两年增速更快
DGX
近两年复合增速
7.3%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.9B | $4.5B |
| 净利润 | $281.0M | $358.7M |
| 毛利率 | — | — |
| 营业利润率 | 15.4% | 11.2% |
| 净利率 | 9.7% | 8.0% |
| 营收同比 | 9.2% | 8.2% |
| 净利润同比 | 12.0% | 11.5% |
| 每股收益（稀释后） | $2.24 | $5.65 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DGXUHS
| Q1 26 | $2.9B | $4.5B | ||
| Q4 25 | $2.8B | $4.5B | ||
| Q3 25 | $2.8B | $4.5B | ||
| Q2 25 | $2.8B | $4.3B | ||
| Q1 25 | $2.7B | $4.1B | ||
| Q4 24 | $2.6B | $4.1B | ||
| Q3 24 | $2.5B | $4.0B | ||
| Q2 24 | $2.4B | $3.9B |
净利润DGXUHS
| Q1 26 | $281.0M | $358.7M | ||
| Q4 25 | $245.0M | $445.9M | ||
| Q3 25 | $245.0M | $373.0M | ||
| Q2 25 | $282.0M | $353.2M | ||
| Q1 25 | $220.0M | $316.7M | ||
| Q4 24 | $222.0M | $332.4M | ||
| Q3 24 | $226.0M | $258.7M | ||
| Q2 24 | $229.0M | $289.2M |
毛利率DGXUHS
| Q1 26 | — | — | ||
| Q4 25 | 32.4% | — | ||
| Q3 25 | 33.7% | — | ||
| Q2 25 | 34.2% | — | ||
| Q1 25 | 32.5% | — | ||
| Q4 24 | 32.7% | — | ||
| Q3 24 | 32.6% | — | ||
| Q2 24 | 33.5% | — |
营业利润率DGXUHS
| Q1 26 | 15.4% | 11.2% | ||
| Q4 25 | 13.8% | 11.5% | ||
| Q3 25 | 13.7% | 11.6% | ||
| Q2 25 | 15.9% | 11.7% | ||
| Q1 25 | 13.0% | 11.1% | ||
| Q4 24 | 13.8% | 11.5% | ||
| Q3 24 | 13.3% | 9.7% | ||
| Q2 24 | 14.8% | 11.2% |
净利率DGXUHS
| Q1 26 | 9.7% | 8.0% | ||
| Q4 25 | 8.7% | 9.9% | ||
| Q3 25 | 8.7% | 8.3% | ||
| Q2 25 | 10.2% | 8.2% | ||
| Q1 25 | 8.3% | 7.7% | ||
| Q4 24 | 8.5% | 8.1% | ||
| Q3 24 | 9.1% | 6.5% | ||
| Q2 24 | 9.6% | 7.4% |
每股收益（稀释后）DGXUHS
| Q1 26 | $2.24 | $5.65 | ||
| Q4 25 | $2.18 | $7.01 | ||
| Q3 25 | $2.16 | $5.86 | ||
| Q2 25 | $2.47 | $5.43 | ||
| Q1 25 | $1.94 | $4.80 | ||
| Q4 24 | $1.95 | $4.94 | ||
| Q3 24 | $1.99 | $3.80 | ||
| Q2 24 | $2.03 | $4.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $393.0M | $119.0M |
| 总债务越低越好 | $5.7B | $4.7B |
| 股东权益账面价值 | $7.7B | $7.5B |
| 总资产 | $16.7B | $15.7B |
| 负债/权益比越低杠杆越低 | 0.74× | 0.63× |
8季度趋势，按日历期对齐
现金及短期投资DGXUHS
| Q1 26 | $393.0M | $119.0M | ||
| Q4 25 | $420.0M | $137.8M | ||
| Q3 25 | $432.0M | $112.9M | ||
| Q2 25 | $319.0M | $137.6M | ||
| Q1 25 | $188.0M | $126.8M | ||
| Q4 24 | $549.0M | $126.0M | ||
| Q3 24 | $764.0M | $106.1M | ||
| Q2 24 | $271.0M | $128.8M |
总债务DGXUHS
| Q1 26 | $5.7B | $4.7B | ||
| Q4 25 | $5.2B | $4.8B | ||
| Q3 25 | $5.2B | $4.7B | ||
| Q2 25 | $5.2B | $4.6B | ||
| Q1 25 | $5.9B | $4.6B | ||
| Q4 24 | $5.6B | $4.5B | ||
| Q3 24 | $5.6B | $4.7B | ||
| Q2 24 | $3.8B | $4.5B |
股东权益DGXUHS
| Q1 26 | $7.7B | $7.5B | ||
| Q4 25 | $7.2B | $7.3B | ||
| Q3 25 | $7.3B | $7.2B | ||
| Q2 25 | $7.2B | $7.0B | ||
| Q1 25 | $6.9B | $6.8B | ||
| Q4 24 | $6.8B | $6.7B | ||
| Q3 24 | $6.8B | $6.6B | ||
| Q2 24 | $6.6B | $6.5B |
总资产DGXUHS
| Q1 26 | $16.7B | $15.7B | ||
| Q4 25 | $16.2B | $15.5B | ||
| Q3 25 | $16.2B | $15.3B | ||
| Q2 25 | $16.0B | $15.0B | ||
| Q1 25 | $15.8B | $14.9B | ||
| Q4 24 | $16.2B | $14.5B | ||
| Q3 24 | $16.1B | $14.4B | ||
| Q2 24 | $13.9B | $14.1B |
负债/权益比DGXUHS
| Q1 26 | 0.74× | 0.63× | ||
| Q4 25 | 0.72× | 0.65× | ||
| Q3 25 | 0.71× | 0.66× | ||
| Q2 25 | 0.72× | 0.65× | ||
| Q1 25 | 0.85× | 0.68× | ||
| Q4 24 | 0.83× | 0.68× | ||
| Q3 24 | 0.83× | 0.71× | ||
| Q2 24 | 0.58× | 0.69× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $278.0M | $401.6M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 3.9% | 4.8% |
| 现金转化率经营现金流/净利润 | 0.99× | 1.12× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DGXUHS
| Q1 26 | $278.0M | $401.6M | ||
| Q4 25 | $465.0M | $574.7M | ||
| Q3 25 | $563.0M | $380.7M | ||
| Q2 25 | $544.0M | $549.0M | ||
| Q1 25 | $314.0M | $360.0M | ||
| Q4 24 | $464.0M | $658.4M | ||
| Q3 24 | $356.0M | $333.0M | ||
| Q2 24 | $360.0M | $679.3M |
自由现金流DGXUHS
| Q1 26 | — | — | ||
| Q4 25 | $307.0M | $293.5M | ||
| Q3 25 | $419.0M | $151.8M | ||
| Q2 25 | $436.0M | $283.0M | ||
| Q1 25 | $197.0M | $121.0M | ||
| Q4 24 | $341.0M | $412.5M | ||
| Q3 24 | $250.0M | $85.0M | ||
| Q2 24 | $268.0M | $437.9M |
自由现金流率DGXUHS
| Q1 26 | — | — | ||
| Q4 25 | 10.9% | 6.5% | ||
| Q3 25 | 14.9% | 3.4% | ||
| Q2 25 | 15.8% | 6.6% | ||
| Q1 25 | 7.4% | 3.0% | ||
| Q4 24 | 13.0% | 10.0% | ||
| Q3 24 | 10.0% | 2.1% | ||
| Q2 24 | 11.2% | 11.2% |
资本支出强度DGXUHS
| Q1 26 | 3.9% | 4.8% | ||
| Q4 25 | 5.6% | 6.3% | ||
| Q3 25 | 5.1% | 5.1% | ||
| Q2 25 | 3.9% | 6.2% | ||
| Q1 25 | 4.4% | 5.8% | ||
| Q4 24 | 4.7% | 6.0% | ||
| Q3 24 | 4.3% | 6.3% | ||
| Q2 24 | 3.8% | 6.2% |
现金转化率DGXUHS
| Q1 26 | 0.99× | 1.12× | ||
| Q4 25 | 1.90× | 1.29× | ||
| Q3 25 | 2.30× | 1.02× | ||
| Q2 25 | 1.93× | 1.55× | ||
| Q1 25 | 1.43× | 1.14× | ||
| Q4 24 | 2.09× | 1.98× | ||
| Q3 24 | 1.58× | 1.29× | ||
| Q2 24 | 1.57× | 2.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
